Table 4.
Characteristics associated with each emotional subscale group (N = 653), with chi-square and F-test results and post-hoc contrasts
| Trajectory group | Chi-square or F-test results | Contrast p-values | ||||||
|---|---|---|---|---|---|---|---|---|
| Characteristic | Consistently Low (n=27) % or Mean(SE) | Recovery to Medium (n=59) % or Mean(SE) | Consistently Medium (n=210) % or Mean(SE) | Declining to Low (n=44) % or Mean(SE) | Consistently High (n=313) % or Mean(SE) | p | Consistently Low vs. Recovery to Medium | Consistently Medium vs. Declining to Low |
| Sociodemographics | ||||||||
| Age | 53.09 (2.40) | 50.17 (1.62) | 54.59 (0.86) | 51.72 (1.88) | 56.70 (0.70) | .001 | .31 | .16 |
| Very/somewhat hard to pay for basics | 44 | 42 | 19 | 23 | 11 | <.001 | .86 | .53 |
| White race | 78 | 76 | 90 | 95 | 92 | .001 | .88 | .29 |
| Children <18 at home | 41 | 42 | 27 | 34 | 20 | .001 | .89 | .35 |
| Cancer-related | ||||||||
| Chemotherapy | ||||||||
| None | 26 | 24 | 35 | 27 | 35 | .03 | .04 | .50 |
| Chemotherapy, no doxorubicin | 22 | 5 | 15 | 21 | 20 | |||
| Chemotherapy, with doxorubicin | 52 | 72 | 50 | 52 | 45 | |||
| Psychosociala | ||||||||
| Role of faith | 6.53(0.92) | 8.74 (0.62) | 8.96 (0.33) | 9.38 (0.73) | 10.74(0.28) | <.001 | .048 | .60 |
| Meaning/peace | 15.57(1.00) | 18.44 (0.67) | 22.46 (0.37) | 21.29 (0.81) | 26.64(0.30) | <.001 | .02 | .19 |
| Social support | 3.68 (0.13) | 4.18 (0.09) | 4.19 (0.05) | 4.14 (0.11) | 4.47 (0.04) | <.001 | .002 | .63 |
| Passive Coping | 1.81 (0.07) | 1.68 (0.04) | 1.33 (0.02) | 1.53 (0.05) | 1.18 (0.02) | <.001 | .08 | <.001 |
| Illness Intrusiveness | 44.04 (3.05) | 47.85 (2.05) | 37.92 (1.11) | 43.64 (2.44) | 29.06 (0.91) | <.001 | .30 | .03 |
| Optimism | 15.63 (0.98) | 17.54 (0.66) | 21.04 (0.35) | 20.18 (0.77) | 24.23 (0.29) | <.001 | .11 | .30 |
a
Values are estimated 4-month values, except for optimism.
Note: College-educated, married/partner, cancer stage, radiation, hormonal therapy, mastectomy, and active coping were not significant; Depressive symptoms was removed due to conceptual overlap.